Laboratory of Structural Biology and AI-based Drug Design

The laboratory aims to establish a platform for innovative drug discovery and design technologies targeting new targets, including structural biology technology, molecular modeling technology, artificial intelligence technology and high-performance computing platform, etc., to study the detailed interaction mechanism between the drugs and their targets, and to conduct innovative drug discovery and design on new targets.

Main Research Focuses:

  • Structure-based drug design and discovery 
  • Multi-scaling molecular modeling of drug-target interaction
  • Drug design and discovery driven by artificial intelligence
  • New tumor marker discovery through multi-omics technologies